Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Anokion Announces Clinical Progress with KAN-101 and ANK-700
Wednesday, September 13, 2023Anokion SA a clinicalstage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance today reported progress for its clinicalstage programs KAN and ANK
Biophytis Obtains Fda Authorization To Initiate The Sara-31 Phase 3 Study In Sarcopenia
Tuesday, September 12, 2023Biophytis announced that it has received FDA Food and Drug Administration authorization to launch its SARA study in the US the first ever phase study in sarcopenia
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Tuesday, September 12, 2023Moderna Inc NASDAQ MRNA Moderna and Immatics NV NASDAQ IMTX Immatics a clinicalstage biopharmaceutical company active in the discovery and development of T cellredirecting cancer immunotherapies today announced a strategic research and development co...
Sandoz announces exclusive deal to commercialize biosimilar ustekinumab further reinforcing growing pipeline and immunology patient offering
Tuesday, September 12, 2023Sandoz a global leader in generic and biosimilar medicines today announced that it has entered into a development and commercialization agreement with Samsung Bioepis
OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease
Tuesday, September 12, 2023OKYO Pharma Limited NASDAQ OKYO a clinical stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory dry eye disease DED a multibilliondollar market and for neuropathic corneal pain NCP
Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results in Late-Breaking Science Session at 2023 AHA Hypertension Scientific Sessions
Tuesday, September 12, 2023Mineralys Therapeutics Inc Nasdaq MLYS a clinicalstage biopharmaceutical company focused on developing medicines to target hypertension chronic kidney disease and other diseases driven by abnormally elevated aldosterone today presented final results...
Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics
Friday, September 08, 2023Lineage Cell Therapeutics Inc NYSE American and TASE LCTX a clinicalstage biotechnology company developing allogeneic cell therapies to replace and restore specific cell types of the human body today announced the initiation of certain development ac...
BioInvent announces achievement of a research milestone event in its collaboration with Exelixis triggering a USD 1 million milestone payment
Friday, September 08, 2023BioInvent International AB BioInvent Nasdaq Stockholm BINV a biotech company focused on the discovery and development of novel and firstinclass immunemodulatory antibodies for cancer immunotherapy
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Thursday, September 07, 2023VBL Therapeutics Nasdaq VBLT VBL today announced that its registration statement on Form S in connection with the proposed merger with Notable Labs Inc Notable has been declared effective by the US Securities and Exchange Commission SEC
UniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy
Wednesday, September 06, 2023UniQure NV NASDAQ QURE a leading gene therapy company advancing transformative therapies for patients with severe medical needs today announced that the US Food and Drug Administration FDA has cleared the Investigational New Drug IND application for...
